Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1111 entries
Sorted by: Best Match Show Resources per page
[Description of actual cases at the clinical training].

Josanpu zasshi = The Japanese journal for midwife

Hirano M, Hario M, Hario S, Oishi S, Imano S, Takahashi Y, Abe Y, Fujishima C, Yurata K, Miura Y, Arakawa A, Kashiwa Y.
PMID: 5198824
Josanpu Zasshi. 1970 Feb;24(2):31-47.

No abstract available.

Cite
Hirano M, Hario M, Hario S, et al. [Description of actual cases at the clinical training]. Josanpu Zasshi. 1970;24(2):31-47
Hirano, M., Hario, M., Hario, S., Oishi, S., Imano, S., Takahashi, Y., Abe, Y., Fujishima, C., Yurata, K., Miura, Y., Arakawa, A., & Kashiwa, Y. (1970). [Description of actual cases at the clinical training]. Josanpu zasshi = The Japanese journal for midwife, 24(2), 31-47.
Hirano, M, et al. "[Description of actual cases at the clinical training]." Josanpu zasshi = The Japanese journal for midwife vol. 24,2 (1970): 31-47.
Hirano M, Hario M, Hario S, Oishi S, Imano S, Takahashi Y, Abe Y, Fujishima C, Yurata K, Miura Y, Arakawa A, Kashiwa Y. [Description of actual cases at the clinical training]. Josanpu Zasshi. 1970 Feb;24(2):31-47. Japanese. PMID: 5198824.
Copy Download .nbib Format: NLM
Allergic bronchopulmonary aspergillosis presenting with a pulmonary mass mimicking lung cancer.

Respirology case reports

Takeuchi Y, Shirai T, Sakurai S, Mikamo M, Fujii M, Suda T.
PMID: 25473526
Respirol Case Rep. 2013 Sep;1(1):5-7. doi: 10.1002/rcr2.4.

A 48-year-old man with a history of asthma visited our hospital for the investigation of a high density mass at the right hilum. Laboratory data revealed elevated serum carcinoembryonic antigen. A bronchoscopy was performed to rule out lung cancer;...

Cite
Takeuchi Y, Shirai T, Sakurai S, et al. Allergic bronchopulmonary aspergillosis presenting with a pulmonary mass mimicking lung cancer. Respirol Case Rep. 2013;1(1):5-7doi: 10.1002/rcr2.4.
Takeuchi, Y., Shirai, T., Sakurai, S., Mikamo, M., Fujii, M., & Suda, T. (2013). Allergic bronchopulmonary aspergillosis presenting with a pulmonary mass mimicking lung cancer. Respirology case reports, 1(1), 5-7. https://doi.org/10.1002/rcr2.4
Takeuchi, Yohei, et al. "Allergic bronchopulmonary aspergillosis presenting with a pulmonary mass mimicking lung cancer." Respirology case reports vol. 1,1 (2013): 5-7. doi: https://doi.org/10.1002/rcr2.4
Takeuchi Y, Shirai T, Sakurai S, Mikamo M, Fujii M, Suda T. Allergic bronchopulmonary aspergillosis presenting with a pulmonary mass mimicking lung cancer. Respirol Case Rep. 2013 Sep;1(1):5-7. doi: 10.1002/rcr2.4. PMID: 25473526; PMCID: PMC4184636.
Copy Download .nbib Format: NLM
Usefulness of influenza vaccination during pregnancy to mothers and young infants.

Expert review of vaccines

Hisano M, Yamaguchi K.
PMID: 23002970
Expert Rev Vaccines. 2012 Aug;11(8):903-5. doi: 10.1586/erv.12.67.

As pregnant women are at increased risk of influenza infection and influenza-related complications, immunization with inactivated influenza vaccine during the influenza season is recommended. Vaccination during pregnancy is considered to provide benefits for both the mothers and their young...

Cite
Hisano M, Yamaguchi K. Usefulness of influenza vaccination during pregnancy to mothers and young infants. Expert Rev Vaccines. 2012;11(8):903-5doi: 10.1586/erv.12.67.
Hisano, M., & Yamaguchi, K. (2012). Usefulness of influenza vaccination during pregnancy to mothers and young infants. Expert review of vaccines, 11(8), 903-5. https://doi.org/10.1586/erv.12.67
Hisano, Michi, and Yamaguchi, Koushi. "Usefulness of influenza vaccination during pregnancy to mothers and young infants." Expert review of vaccines vol. 11,8 (2012): 903-5. doi: https://doi.org/10.1586/erv.12.67
Hisano M, Yamaguchi K. Usefulness of influenza vaccination during pregnancy to mothers and young infants. Expert Rev Vaccines. 2012 Aug;11(8):903-5. doi: 10.1586/erv.12.67. PMID: 23002970.
Copy Download .nbib Format: NLM
Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease.

Lung India : official organ of Indian Chest Society

Dragonieri S, Quaranta VN, Carratu P, Lacedonia D, Carpagnano GE, Milano A, D'Alba G, Ranieri T, Barbaro MP, Resta O.
PMID: 27625465
Lung India. 2016 Sep-Oct;33(5):579-80. doi: 10.4103/0970-2113.189000.

No abstract available.

Cite
Dragonieri S, Quaranta VN, Carratu P, et al. Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease. Lung India. 2016;33(5):579-80doi: 10.4103/0970-2113.189000.
Dragonieri, S., Quaranta, V. N., Carratu, P., Lacedonia, D., Carpagnano, G. E., Milano, A., D'Alba, G., Ranieri, T., Barbaro, M. P., & Resta, O. (2016). Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease. Lung India : official organ of Indian Chest Society, 33(5), 579-80. https://doi.org/10.4103/0970-2113.189000
Dragonieri, Silvano, et al. "Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease." Lung India : official organ of Indian Chest Society vol. 33,5 (2016): 579-80. doi: https://doi.org/10.4103/0970-2113.189000
Dragonieri S, Quaranta VN, Carratu P, Lacedonia D, Carpagnano GE, Milano A, D'Alba G, Ranieri T, Barbaro MP, Resta O. Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease. Lung India. 2016 Sep-Oct;33(5):579-80. doi: 10.4103/0970-2113.189000. PMID: 27625465; PMCID: PMC5006351.
Copy Download .nbib Format: NLM
Estimation of the Proportion of Underachieving Students in Compulsory Secondary Education in Spain: An Application of the Rasch Model.

Frontiers in psychology

Veas A, Gilar R, Miñano P, Castejón JL.
PMID: 26973586
Front Psychol. 2016 Mar 04;7:303. doi: 10.3389/fpsyg.2016.00303. eCollection 2016.

There are very few studies in Spain that treat underachievement rigorously, and those that do are typically related to gifted students. The present study examined the proportion of underachieving students using the Rasch measurement model. A sample of 643...

Cite
Veas A, Gilar R, Miñano P, et al. Estimation of the Proportion of Underachieving Students in Compulsory Secondary Education in Spain: An Application of the Rasch Model. Front Psychol. 2016;7:303doi: 10.3389/fpsyg.2016.00303.
Veas, A., Gilar, R., Miñano, P., & Castejón, J. L. (2016). Estimation of the Proportion of Underachieving Students in Compulsory Secondary Education in Spain: An Application of the Rasch Model. Frontiers in psychology, 7303. https://doi.org/10.3389/fpsyg.2016.00303
Veas, Alejandro, et al. "Estimation of the Proportion of Underachieving Students in Compulsory Secondary Education in Spain: An Application of the Rasch Model." Frontiers in psychology vol. 7 (2016): 303. doi: https://doi.org/10.3389/fpsyg.2016.00303
Veas A, Gilar R, Miñano P, Castejón JL. Estimation of the Proportion of Underachieving Students in Compulsory Secondary Education in Spain: An Application of the Rasch Model. Front Psychol. 2016 Mar 04;7:303. doi: 10.3389/fpsyg.2016.00303. eCollection 2016. PMID: 26973586; PMCID: PMC4777898.
Copy Download .nbib Format: NLM
The 24-hour skin hydration and barrier function effects of a hyaluronic 1%, glycerin 5%, and .

Clinical, cosmetic and investigational dermatology

Milani M, Sparavigna A.
PMID: 28860834
Clin Cosmet Investig Dermatol. 2017 Aug 11;10:311-315. doi: 10.2147/CCID.S144180. eCollection 2017.

INTRODUCTION: Moisturizing products are commonly used to improve hydration in skin dryness conditions. However, some topical hydrating products could have negative effects on skin barrier function. In addition, hydrating effects of moisturizers are not commonly evaluated up to 24...

Cite
Milani M, Sparavigna A. The 24-hour skin hydration and barrier function effects of a hyaluronic 1%, glycerin 5%, and . Clin Cosmet Investig Dermatol. 2017;10:311-315doi: 10.2147/CCID.S144180.
Milani, M., & Sparavigna, A. (2017). The 24-hour skin hydration and barrier function effects of a hyaluronic 1%, glycerin 5%, and . Clinical, cosmetic and investigational dermatology, 10311-315. https://doi.org/10.2147/CCID.S144180
Milani, Massimo, and Sparavigna, Adele. "The 24-hour skin hydration and barrier function effects of a hyaluronic 1%, glycerin 5%, and ." Clinical, cosmetic and investigational dermatology vol. 10 (2017): 311-315. doi: https://doi.org/10.2147/CCID.S144180
Milani M, Sparavigna A. The 24-hour skin hydration and barrier function effects of a hyaluronic 1%, glycerin 5%, and . Clin Cosmet Investig Dermatol. 2017 Aug 11;10:311-315. doi: 10.2147/CCID.S144180. eCollection 2017. PMID: 28860834; PMCID: PMC5560567.
Copy Download .nbib Format: NLM
Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging.

Journal of medical ultrasonics (2001)

Wen YL, Kudo M, Minami Y, Chung H, Suetomi Y, Onda H, Kitano M, Kawasaki T, Maekawa K.
PMID: 27278304
J Med Ultrason (2001). 2003 Sep;30(3):141-51. doi: 10.1007/BF02481219.

OBJECTIVE: To compare the effectiveness of contrast-enhanced Dynamic Flow imaging and contrast-enhanced power Doppler imaging using Levovist(®) as a microbubble contrast agent in evaluating intratumoral vascularity in hepatocellular carcinoma (HCC).MATERIALS AND METHODS: Twenty-nine patients with 54 hepatocellular carcinoma nodules...

Cite
Wen YL, Kudo M, Minami Y, et al. Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging. J Med Ultrason (2001). 2003;30(3):141-51doi: 10.1007/BF02481219.
Wen, Y. L., Kudo, M., Minami, Y., Chung, H., Suetomi, Y., Onda, H., Kitano, M., Kawasaki, T., & Maekawa, K. (2003). Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging. Journal of medical ultrasonics (2001), 30(3), 141-51. https://doi.org/10.1007/BF02481219
Wen, Yan Ling, et al. "Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging." Journal of medical ultrasonics (2001) vol. 30,3 (2003): 141-51. doi: https://doi.org/10.1007/BF02481219
Wen YL, Kudo M, Minami Y, Chung H, Suetomi Y, Onda H, Kitano M, Kawasaki T, Maekawa K. Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging. J Med Ultrason (2001). 2003 Sep;30(3):141-51. doi: 10.1007/BF02481219. PMID: 27278304.
Copy Download .nbib Format: NLM
Nontoxic organic solvents identified using an a priori approach with Hansen solubility parameters.

Chemical communications (Cambridge, England)

Nakamura D, Hirano M, Ohta R.
PMID: 28345101
Chem Commun (Camb). 2017 Apr 06;53(29):4096-4099. doi: 10.1039/c7cc01434a.

Nontoxicities of organic solvents were predicted using Hansen solubility parameters and various truly nontoxic solvents were identified according to the prediction. The nontoxicity of solvents originates from their exhibition of poor solubility or low diffusivity toward cell constituents and...

Cite
Nakamura D, Hirano M, Ohta R. Nontoxic organic solvents identified using an a priori approach with Hansen solubility parameters. Chem Commun (Camb). 2017;53(29):4096-4099doi: 10.1039/c7cc01434a.
Nakamura, D., Hirano, M., & Ohta, R. (2017). Nontoxic organic solvents identified using an a priori approach with Hansen solubility parameters. Chemical communications (Cambridge, England), 53(29), 4096-4099. https://doi.org/10.1039/c7cc01434a
Nakamura, Daisuke, et al. "Nontoxic organic solvents identified using an a priori approach with Hansen solubility parameters." Chemical communications (Cambridge, England) vol. 53,29 (2017): 4096-4099. doi: https://doi.org/10.1039/c7cc01434a
Nakamura D, Hirano M, Ohta R. Nontoxic organic solvents identified using an a priori approach with Hansen solubility parameters. Chem Commun (Camb). 2017 Apr 06;53(29):4096-4099. doi: 10.1039/c7cc01434a. PMID: 28345101.
Copy Download .nbib Format: NLM
Looking ahead and looking back: happy birthday joints!.

Joints

Milano G.
PMID: 25606534
Joints. 2014 May 08;2(1):5. eCollection 2014.

No abstract available.

Cite
Milano G. Looking ahead and looking back: happy birthday joints!. Joints. 2014;2(1):5
Milano, G. (2014). Looking ahead and looking back: happy birthday joints!. Joints, 2(1), 5.
Milano, Giuseppe. "Looking ahead and looking back: happy birthday joints!." Joints vol. 2,1 (2014): 5.
Milano G. Looking ahead and looking back: happy birthday joints!. Joints. 2014 May 08;2(1):5. eCollection 2014. PMID: 25606534; PMCID: PMC4295660.
Copy Download .nbib Format: NLM
Carcinoid tumor of the extrahepatic bile duct: report of a case.

Clinical journal of gastroenterology

Yasuda T, Imai G, Takemoto M, Yamasaki M, Ishikawa H, Kitano M, Nakai T, Takeyama Y.
PMID: 26181459
Clin J Gastroenterol. 2013 Apr;6(2):177-87. doi: 10.1007/s12328-013-0373-2. Epub 2013 Mar 23.

We report a rare case of carcinoid tumor of the extrahepatic bile duct. A 69-year-old woman with a history of hyperthyroidism was diagnosed to have a tumor of the extrahepatic bile duct. Laparotomy, for presumed cholangiocarcinoma, revealed a 2.5-cm-long,...

Cite
Yasuda T, Imai G, Takemoto M, et al. Carcinoid tumor of the extrahepatic bile duct: report of a case. Clin J Gastroenterol. 2013;6(2):177-87doi: 10.1007/s12328-013-0373-2.
Yasuda, T., Imai, G., Takemoto, M., Yamasaki, M., Ishikawa, H., Kitano, M., Nakai, T., & Takeyama, Y. (2013). Carcinoid tumor of the extrahepatic bile duct: report of a case. Clinical journal of gastroenterology, 6(2), 177-87. https://doi.org/10.1007/s12328-013-0373-2
Yasuda, Takeo, et al. "Carcinoid tumor of the extrahepatic bile duct: report of a case." Clinical journal of gastroenterology vol. 6,2 (2013): 177-87. doi: https://doi.org/10.1007/s12328-013-0373-2
Yasuda T, Imai G, Takemoto M, Yamasaki M, Ishikawa H, Kitano M, Nakai T, Takeyama Y. Carcinoid tumor of the extrahepatic bile duct: report of a case. Clin J Gastroenterol. 2013 Apr;6(2):177-87. doi: 10.1007/s12328-013-0373-2. Epub 2013 Mar 23. PMID: 26181459.
Copy Download .nbib Format: NLM
A case of severe ganciclovir-induced encephalopathy.

Case reports in neurology

Sakamoto H, Hirano M, Nose K, Ueno S, Oki T, Sugimoto K, Nishioka T, Kusunoki S, Nakamura Y.
PMID: 24403897
Case Rep Neurol. 2013 Oct 05;5(3):183-6. doi: 10.1159/000355638. eCollection 2013.

BACKGROUND: Ganciclovir, a drug against cytomegalovirus (CMV) infection, is generally well tolerated, but can cause neurotoxicity such as encephalopathy. Although ganciclovir-induced encephalopathy has been described in several reports, a literature search revealed that ganciclovir concentrations in the blood or...

Cite
Sakamoto H, Hirano M, Nose K, et al. A case of severe ganciclovir-induced encephalopathy. Case Rep Neurol. 2013;5(3):183-6doi: 10.1159/000355638.
Sakamoto, H., Hirano, M., Nose, K., Ueno, S., Oki, T., Sugimoto, K., Nishioka, T., Kusunoki, S., & Nakamura, Y. (2013). A case of severe ganciclovir-induced encephalopathy. Case reports in neurology, 5(3), 183-6. https://doi.org/10.1159/000355638
Sakamoto, Hikaru, et al. "A case of severe ganciclovir-induced encephalopathy." Case reports in neurology vol. 5,3 (2013): 183-6. doi: https://doi.org/10.1159/000355638
Sakamoto H, Hirano M, Nose K, Ueno S, Oki T, Sugimoto K, Nishioka T, Kusunoki S, Nakamura Y. A case of severe ganciclovir-induced encephalopathy. Case Rep Neurol. 2013 Oct 05;5(3):183-6. doi: 10.1159/000355638. eCollection 2013. PMID: 24403897; PMCID: PMC3884185.
Copy Download .nbib Format: NLM
β,β-Diborylated Subporphyrinato Boron(III) Complexes as Useful Synthetic Precursors.

Angewandte Chemie (International ed. in English)

Kitano M, Okuda Y, Tsurumaki E, Tanaka T, Yorimitsu H, Osuka A.
PMID: 26088764
Angew Chem Int Ed Engl. 2015 Aug 03;54(32):9275-9. doi: 10.1002/anie.201503530. Epub 2015 Jun 18.

Iridium-catalyzed borylation of B-aryl meso-free subporphyrinato boron(III) complexes (hereinafter referred to simply as subporphyrins) with bis(pinacolato)diboron gave 2,13-diborylated subporphyrins regioselectively, which served as promising synthetic precursors for 2,13-diarylated subporphyrins and doubly β-to-β 1,3-butadiyne-bridged subporphyrin dimers. 2,13-Diarylated subporphyrins display perturbed...

Cite
Kitano M, Okuda Y, Tsurumaki E, et al. β,β-Diborylated Subporphyrinato Boron(III) Complexes as Useful Synthetic Precursors. Angew Chem Int Ed Engl. 2015;54(32):9275-9doi: 10.1002/anie.201503530.
Kitano, M., Okuda, Y., Tsurumaki, E., Tanaka, T., Yorimitsu, H., & Osuka, A. (2015). β,β-Diborylated Subporphyrinato Boron(III) Complexes as Useful Synthetic Precursors. Angewandte Chemie (International ed. in English), 54(32), 9275-9. https://doi.org/10.1002/anie.201503530
Kitano, Masaaki, et al. "β,β-Diborylated Subporphyrinato Boron(III) Complexes as Useful Synthetic Precursors." Angewandte Chemie (International ed. in English) vol. 54,32 (2015): 9275-9. doi: https://doi.org/10.1002/anie.201503530
Kitano M, Okuda Y, Tsurumaki E, Tanaka T, Yorimitsu H, Osuka A. β,β-Diborylated Subporphyrinato Boron(III) Complexes as Useful Synthetic Precursors. Angew Chem Int Ed Engl. 2015 Aug 03;54(32):9275-9. doi: 10.1002/anie.201503530. Epub 2015 Jun 18. PMID: 26088764.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1111 entries